Peregrine Pharma, which as everyone should know by now has, like Resverlogix, investment by Eastern's Mr. Dart. They're also at a similar stage with bavituximab as Resverlogix is with RVX-208....heading into stage 3 in the coming months. They're going after a cancer treatment though, not RRR in MACE for a variety of diseases.

To put things in perspective, back in 2000 PPHM was trading over $40 per share. Today? Not so good....it closed at $1.15 today. Market cap about 230 million USD. An apple and an orange? Maybe...but I think its more like a Red Delicious versus a Granny Smith.

Some have complained that DM is overpaid, pulling in a salary of $500,000 CDN. Well Peregrine's CEO makes 3 times that amount, and in USD not our Norther Peso.

http://www.conferencecalltranscripts.org/proxy/summary2/?id=1970659

If DM worked at Peregrine for the $$$ he's making with RVX....he wouldn't even be in the top 5 in terms of payroll. And Peregrine isn't making any $$$ either, their earnings for the trailing 12 months were (-$0.30) per share.

Now Don is going to read this and feel grossly underpaid.....